Hoechst S 769121
CAS : 74681-68-8
Ref. 3D-ZCA68168
| 1mg | À demander | ||
| 5mg | À demander | ||
| 10mg | À demander | ||
| 25mg | À demander | ||
| 50mg | À demander |
Informations sur le produit
- 4-(5-(4-Methyl-1-piperazinyl)(2,5'-bi-1H-benzimidazol)-2'-yl)benzenesulfonamide trihydrochloride
- 4-[5-(4-Methyl-1-piperazinyl)[2,5′-bi-1H-benzimidazol]-2′-yl]-benzenesulfonamide
- 4-[6-(4-methylpiperazin-1-yl)-1H,3'H-2,5'-bibenzimidazol-2'-yl]benzenesulfonamide trihydrochloride
- Benzenesulfonamide, 4-[5-(4-methyl-1-piperazinyl)[2,5′-bi-1H-benzimidazol]-2′-yl]-, hydrochloride (1:3)
- Benzenesulfonamide, 4-[5-(4-methyl-1-piperazinyl)[2,5′-bi-1H-benzimidazol]-2′-yl]-, trihydrochloride
- Hoe-S769121
Hoechst S 769121 is a research chemical that has various applications in the field of pharmaceutical research. It has been studied for its potential in combination with other drugs such as canagliflozin, lenvatinib, dimethyl fumarate, glimepiride, sorafenib, and more. Hoechst S 769121 exhibits unique properties such as strong pyridinium emission and nuclear localization. This compound has shown promise in preclinical studies involving lenvatinib treatment and has been found to have interactions with phosphoric acid, diacetone, taurine, positron emission, and proton. Researchers are continuing to explore the potential uses and mechanisms of action of Hoechst S 769121 in various therapeutic areas.
Propriétés chimiques
Question d’ordre technique sur : 3D-ZCA68168 Hoechst S 769121
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
